|
FN3KRP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.562900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.092000E-02 |
| Normal-vs-Stage2 |
1.843610E-02 |
| Normal-vs-Stage3 |
1.178960E-03 |
| Normal-vs-Stage4 |
2.576900E-03 |
| Stage1-vs-Stage2 |
4.112400E-01 |
| Stage1-vs-Stage3 |
1.738370E-01 |
| Stage1-vs-Stage4 |
1.808200E-01 |
| Stage2-vs-Stage3 |
9.512400E-01 |
| Stage2-vs-Stage4 |
8.583000E-01 |
| Stage3-vs-Stage4 |
8.709200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.562100E-03 |
| Normal-vs-AfricanAmerican |
6.204000E-01 |
| Normal-vs-Asian |
2.264300E-02 |
| Caucasian-vs-AfricanAmerican |
2.116400E-01 |
| Caucasian-vs-Asian |
7.197200E-01 |
| AfricanAmerican-vs-Asian |
2.329400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.367700E-04 |
| Normal-vs-Female |
1.542320E-02 |
| Male-vs-Female |
1.161600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.135900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.721700E-03 |
| Normal-vs-Age(61-80Yrs) |
9.011500E-04 |
| Normal-vs-Age(81-100Yrs) |
9.895900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.433400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.044200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.069200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.415160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.171000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.516600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.572800E-01 |
| Classical-VS-Follicular |
1.810130E-04 |
| Classical-VS-Other |
2.631600E-01 |
| Classical-VS-Normal |
7.244100E-02 |
| Tall-VS-Follicular |
1.078040E-01 |
| Tall-VS-Other |
6.028000E-01 |
| Tall-VS-Normal |
3.161600E-02 |
| Follicular-VS-Other |
7.759600E-01 |
| Follicular-VS-Normal |
8.26870000000257E-05 |
| Other-VS-Normal |
9.987900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.428000E-02 |
| Normal-vs-N1 |
3.041500E-04 |
| N0-vs-N1 |
7.906300E-02 |
|
|
